• Skip to primary navigation
  • Skip to main content

Mackenzie's Mission HomepageMackenzie's Mission

DONATE Mackenzies Mission Donate
  • Mission
  • About
    • The Story
    • Board
  • Resources
    • Resource List
    • What Is Amyloidosis
  • Speakers Bureau
    • About ASB
    • ASB Operating Committee
  • Fundraisers
  • Blog
  • Contact

"What lies behind you and what lies in front of you, pales in comparison to what lies inside of you."
Ralph Waldo Emerson

Blog

Inflation Reduction Act of 2022 & Amyloidosis

August 31, 2023

Despite the well-intended goal of lowering prescription drug costs generally and allowing drug prices for Medicare recipients to be negotiated, there remains much to unravel about the effects of the new Inflation Reduction Act. It will likely save many people money but there is concern, especially regarding the medications for the treatment of rare diseases such as amyloidosis, and about what appears to be a disincentive to pharmaceutical companies to engage in costly research and development to treat these rare diseases. The challenge to diagnosis and providing effective, affordable treatment to amyloidosis patients continues.

Filed Under: Featured News Tagged With: amyloidosis, amyloidosis news, amyloidosis treatment

A Patient Guide for Understanding Amyloidosis

July 25, 2023

Amyloidosis is a multi-system disease, making diagnosis challenging. In this informative patient guide, the American Society of Nuclear Cardiology (ASNC) discusses common symptoms, types of amyloidosis, red flags to be aware of, diagnostic tests and available treatment options.

Filed Under: Featured News, What Is Amyloidosis Tagged With: AL amyloidosis, Amyloid cardiomyopathy, amyloidosis, amyloidosis diagnosis, ATTR amyloidosis, ATTR-CA, ATTR-CM, attrv, ATTRwt, cardiac amyloidosis, diagnosing amyloidosis, hATTR, Hereditary Amyloidosis, light chain amyloidosis, wild-type amyloidosis

Multidisciplinary Care for Cardiac Amyloidosis Patients

June 24, 2023

Multi-systemic diseases such as amyloidosis are not only complex to diagnose, but also complex in the treatment and ongoing patient care. It takes a village. In this seminal piece, the American College of Cardiology (ACC) provides an Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis. An absolute must-read for cardiologists and other specialties such as neurology, gastroenterology, nephrology and hematology.

Filed Under: Featured News, What Is Amyloidosis Tagged With: AL amyloidosis, Amyloid cardiomyopathy, amyloidosis, amyloidosis treatment, ATTR amyloidosis, ATTR-CM, attrv, ATTRwt, cardiac amyloidosis, cardiology, gastroenterology, hATTR, heart failure, hematology, Hereditary Amyloidosis, light chain amyloidosis, nephrology, neurology, wild-type amyloidosis

ATTR-CM: Don’t Assume it’s Wild-Type TTR Amyloidosis

May 25, 2023

Historically it has been thought that the majority of elderly cardiomyopathy patients diagnosed with amyloidosis, ATTR-CM, transthyretin amyloid cardiomyopathy, suffered from wild-type, a non-genetic version of the disease that most commonly affects but is not exclusive to men over seventy years of age. A study in the UK conducted from January 2010 through August 2022 was conducted to determine whether this was true. Here we summarize their fascinating findings.

Filed Under: Featured News, Uncategorized, What Is Amyloidosis Tagged With: Amyloid cardiomyopathy, amyloidosis, amyloidosis diagnosis, ATTR amyloidosis, ATTR-CM, ATTRwt, cardiomyopathy, diagnosing amyloidosis, wild-type amyloidosis

Helping Patients Find Their Voice

April 27, 2023

Developing one’s “patient voice” can seem unduly intimidating. Advocating one’s position may come natural to some, but terrifying for others, especially when the physician is viewed as the expert. Additionally, many patients may find it difficult to translate their feelings without having a medical vocabulary. Here are some ideas for healthcare professionals to help their patients find their voice.

Filed Under: Featured News Tagged With: advocacy, amyloidosis, patient advocacy, patient support

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 20
  • Go to Next Page »

Be A Part Of Our Mission!

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!

  • Mission
  • About
  • Resources
  • Speakers Bureau
  • Fundraisers
  • Blog
  • Contact

Registered 501(c)(3) · Contact · Copyright © 2023 · Mackenzies Mission - All Rights Reserved